Periodic fever syndromes

Pediatrics in Review

Volumn 30, Issue 5, 2009, Pages

  Goldsmith, Donald P ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIMETIDINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; ETANERCEPT; GLUCOCORTICOID; MEVALONATE KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THALIDOMIDE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; AUTOINFLAMMATORY DISEASE; CINCA SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; MUCKLE WELLS SYNDROME; PFAPA SYNDROME; RECURRENT FEVER; TONSILLECTOMY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

CHILD; CHILD, PRESCHOOL; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; FAMILIAL MEDITERRANEAN FEVER; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; LYMPHADENITIS; MEVALONATE KINASE DEFICIENCY; RECEPTORS, TUMOR NECROSIS FACTOR; STOMATITIS, APHTHOUS;

EID: 76149128376     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.30-5-e34     Document Type: Article

References (40)

1. Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol. 2006;18:108-117
2. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1-11
3. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997; 90:797-807
4. A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet. 1997;17:25-31
5. Touitou I, Notarnicola C, Grandemange S. Identifying mutations in autoinflammatory diseases: towards novel genetic tests and therapies. Am J Pharmacogenet. 2004;4:109-118
6. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001-1005
7. Belkhir R, Moulonguet-Doleris L, Hachulla E, Prinseau J, Baglin A, Hanslik T. Treatment of familial Mediterranean fever with anakinra. Ann Intern Med. 2007;146:825-826
8. Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol. 2006:24(5 suppl 42):S99-S103
9. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BHB, Toghill PJ. Familial Hibernian fever. Q J Med. 1982;204:469-480
10. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 KDA TNF receptor, TNFRI, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-144
11. Masson C, Simon V, Hoppe E, Insalaco P, Sisse I, Audron M. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic disease. Joint Bone Spine. 2004;71:284-290
12. Drewe E, Lanyon PC, Powell RJ. Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome. Comment on the articles by Hill et al and Dode et al. Arthritis Rheum. 2003;48:1768-1769
13. Gattorno M, Pelagatti MA, Meini A, et al. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008;58:1516-1520
14. Van der Meer JW, Vassen JM, Radi J, et al. Hyperimmunoglobulin D and periodic fever: a new syndrome. Lancet. 1984;1: 1087-1090
15. Drenth JP, Haagsma CJ, Van der Meer JW. Hyperimmunoglobulin D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD study group. Medicine. 1994;73:133-144
16. Drenth JP, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet. 1999;22:178-181
17. Houten SM, Kuis W, Duran M, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinemia D and periodic fever syndrome. Nat Genet. 1999;22:175-177
18. Simon A, Drewe E, Van der Meer JW, et al. Simvastin treatment for inflammatory attacks of the hyperimmunoglobulin D and periodic fever syndrome. Clin Pharmacol Ther. 2004;75:476
19. Ryan JG, Goldbach-Mansky R. The spectrum of autoinflammatory diseases: recent bench to bedside observations. Curr Opin Rheumatol. 2008;20:66-74
20. Bodar EJ, Hilst JC, Drenth JP, Van der Meer JW, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005;63:260-264
21. Feldmann J, Prieur A-M, Quartier P, et al. Chronic infantile neurologic cutaneous and articular syndrome is caused by mutations in CIASI, a gene highly expressed in poly-morphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71:198-203
22. Aksentijevich I, Nowak M, Mallak M, et al. De novo CIASI mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multi-system inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340-3351
23. Cuisset L, Drenth JP, Berthelor J-M, et al. Genetic linkage of the Muckle-Wells syndrome to chromosome1q44. Am J Hum Genet. 1999;65:1054-1059
24. Hoffman HM, Wright FA, Broide DH, et al. Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet. 2000;66:1693-1698
25. Kile RL, Rusk HA. A case of cold urticaria with an unusual family history. JAMA. 1940;114:1067-1068
26. Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med. 1962;31:235-248
27. Hassink SG, Goldsmith DP. Neonatal onset multisystem inflammatory disease (NOMID). Arthritis Rheum. 1983; 26: 668-673
28. Prieur AM, Griscelli C. Nosologic aspects of systemic forms of very early onset juvenile arthritis. Apropos of 17 cases. Ann Pediatr (Paris). 1983;30:565
29. Askentijevich I, Putnam CB, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56:1273-1285
30. Goldbach-Mansky R, Dailey NJ, Cana SW, et al. Neonatal onset multisystem inflammatory disease responsive to interleukin 1 beta inhibition. N Engl J Med. 2006;24:85-89
31. Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr. 1987;110:43-46
32. Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999;135:15-21
33. Padeh S, Brezniak N, Zemer D, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr. 1999;135:98-101
34. Cazeneuve C, Geneviève D, Amselem S, Hentgen V, Hau I, Reinert P. MEFV gene analysis in PFAPA. J Pediatr. 2003;142: 140-141
35. Maschio M, Oretti C, Ventura G, et al. CARD15/NOD2 mutations are not related to abdominal PFAPA. J Pediatr. 2006; 149:427
36. Feder HM Jr. Cimetidine treatment for periodic fever associated with aphthous stomatitis, pharyngitis, and cervical adenitis. Pediatr Infect Dis J. 1992;11:318-321
37. Tasher D, Somkh E, Dalal I, et al. PFAPA syndrome: new clinical aspects disclosed. Arch Dis Child. 2006;91:981-984
38. Renko M, Salo E, Putt-Laurila A, et al. A randomized controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr. 2007;151: 289-292
39. Licameli G, Jeffrey J, Luz J, et al. Effect of adenotonsillectomy in PFAPA syndrome. Arch Otolaryngol Head Neck Surg. 2008;134: 136-140
40. Gattorno M, Sormani P, D'Osualdo A, et al. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum. 2008;55:1823-1832